Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

New head of oncology for Astellas Pharma Europe

August 16, 2011 Research and Development, Sales and Marketing appointment, research and development, sales and marketing

Astellas Pharma has appointed Dr Christopher Thomson as executive director of its new European Oncology Unit.   Dr Thomson will …
Appointment
GlaxoSmithKline

GSK Parkinson’s drug shows motor skills benefits

August 16, 2011 Research and Development GSK, Impax Pharmaceuticals, Parkinson's disease, research and development news

GlaxoSmithKline’s new drug IPX066 has helped Parkinson’s disease patients retain their motor skills after their medication wore off. IPX066, which …
News

Afrezza could breathe new life into inhaled insulin market

August 15, 2011 Research and Development, Sales and Marketing diabetes, inhaled insulin, insulin, research and development news

New trials for MannKind’s investigational inhaled insulin drug Afrezza have been given the go-ahead by the FDA, potentially breathing new …
News

Study shows new genetic risk factors for MS

August 15, 2011 Research and Development genes, multiple sclerosis, research and development news

New genetic links to the immune system have been identified as a possible trigger for multiple sclerosis. The exact causes …
News

Nanoparticles to target Alzheimer’s disease

August 10, 2011 Research and Development Alzheimer's, nanoparticles

Researchers at Lancaster University funded by the European Union are hoping to develop a new treatment for Alzheimer’s disease. Nanoparticles …
News

New MS drug shows promise for Abbott

August 10, 2011 Research and Development, Sales and Marketing Abbott, Avonex, Biogen, MS, gilenya

Biogen and Abbott’s multiple sclerosis drug daclizumab has performed well in a mid-stage trial, but two deaths marred the overall …
News

Pfizer teams up with University of California for drug discovery

August 9, 2011 Research and Development, Sales and Marketing Pfizer, academic research

Pfizer has signed a deal with the University of California to help expand its drug discovery and development programme. The …
News

Takeda and Amylin stop obesity trial

August 8, 2011 Research and Development, Sales and Marketing Amylin, Takeda

Takeda and Amylin have decided to halt further studies of its combination treatment for obesity, due to ‘evolving dynamics’ within …
News
Pfizer building

Biotica becomes new victim of Pfizer’s R&D downsizing

August 8, 2011 Research and Development, Sales and Marketing

Pfizer has pulled out of a $195 million deal with UK firm Biotica, as it continues to downsize its global …
News

Meet Wainwright Associates at the TOPRA Symposium and CPhl worldwide

August 7, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates

Wainwright Associates is an independent company offering consultancy services to the pharmaceutical, medical device and healthcare industry in Product Development, …
News
Press release

Mergers and spending cuts damaging drug research

August 3, 2011 Research and Development, Sales and Marketing LaMattina, Pfizer, research productivity

Big pharma’s policy of mergers and swingeing cuts is having a devastating effect on drug research, says a former Pfizer …
News

Actelion’s MS candidate shows promise

August 2, 2011 Research and Development Actelion, MS

Actelion’s prospective multiple sclerosis pill ponesimod has cheered the company by meeting its primary endpoint in a phase IIb trial. …
News

Teva’s MS treatment disappoints

August 2, 2011 Research and Development, Sales and Marketing Laquinimod, MS, Teva

Teva and Active Biotech’s oral MS drug laquinimod has failed to meet its primary endpoint in a phase III trial. …
News

Witty backs Britain as manufacturing, R&D location

July 29, 2011 Manufacturing and Production, Research and Development GSK

GlaxoSmithKline chief executive Andrew Witty has promised to expand operations in the UK in both manufacturing and R&D, saying that …
News
GlaxoSmithKline

GSK sales down on Avandia and pandemic products

July 27, 2011 Research and Development, Sales and Marketing GSK

GlaxoSmithKline has posted a slide in revenue for the second quarter, but is buoyed by strong underlying growth. Sales were …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025